Sinovac Biotech Stock Price Patterns

Intrinsic Valuation Low Real High 6.47 6.47 6.47 Details

Earnings Estimates (0) Low Projected EPS High -0.03 -0.02 -0.02 Details

Sinovac Biotech After-Hype Price Density Analysis

Sinovac Biotech Estimiated After-Hype Price Volatility

Sinovac Biotech Stock Price Outlook Analysis

Notes

Sinovac Biotech Hype Timeline

On the 9th of February Sinovac Biotech is traded for 6.47. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Sinovac is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is at this time at 0.0%. %. The volatility of related hype on Sinovac Biotech is about 0.0%, with the expected price after the next announcement by competition of 6.47. About 51.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.82. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Sinovac Biotech had not issued any dividends in recent years. Considering the 90-day investment horizon the next anticipated press release will be in about 4 days. Check out Sinovac Biotech Basic Forecasting Models to cross-verify your projections. For information on how to trade Sinovac Stock refer to our How to Trade Sinovac Stock guide.

Sinovac Biotech Related Hype Analysis

Sinovac Biotech Additional Predictive Modules

Most predictive techniques to examine Sinovac price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Sinovac using various technical indicators. When you analyze Sinovac charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

The successful prediction of Sinovac Biotech stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Sinovac Biotech, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Sinovac Biotech based on analysis of Sinovac Biotech hews, social hype, general headline patterns, and widely used predictive technical indicators.

When running Sinovac Biotech's price analysis, check to measure Sinovac Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sinovac Biotech is operating at the current time. Most of Sinovac Biotech's value examination focuses on studying past and present price action to predict the probability of Sinovac Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sinovac Biotech's price. Additionally, you may evaluate how the addition of Sinovac Biotech to your portfolios can decrease your overall portfolio volatility.